| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | +32.9% |
| Cost of Revenue | $563K | +55.5% |
| Gross Profit | $3.0M | +29.4% |
| R&D Expense | $494K | +139.5% |
| SG&A Expense | $8.1M | -9.9% |
| Operating Income | -$7.8M | -9.4% |
| Interest Expense | $74K | -57.6% |
| Net Income | -$7.8M | +5.4% |
| EPS (Basic) | -$0.95 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | +34.3% |
| Accounts Receivable | $196K | -20.0% |
| Inventory | $257K | +480.1% |
| Current Assets | $5.7M | +34.4% |
| Total Assets | $6.4M | +34.6% |
| Current Liabilities | $2.8M | +14.7% |
| Total Liabilities | $3.0M | +11.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -5.5% |
| Capital Expenditures | $31K | +12.1% |
| Investing Cash Flow | -$131K | -372.2% |
| Financing Cash Flow | $7.8M | -19.6% |
| Free Cash Flow | -$6.5M | -5.5% |
| +22.1% |
| EPS (Diluted) | -$0.95 | +22.1% |
| Stockholders' Equity |
| $3.4M |
| +64.4% |